Seth Whitelaw

Mitchell Hamline School of Law, Compliance, Faculty Member

Followers

Following

Public Views

Dr. Whitelaw has 30 years of industry experience in the life sciences and health care sectors, as an attorney, compliance officer (C.R. Bard, Inc., GlaxoSmithKline, and Misonix, Inc.) and industry consultant (Deloitte, Whitelaw Compliance Group LLC.). Most recently, he served as a compliance expert in the Opioid MDL litigation.In addition to being a Food and Drug Law Institute (FDLI) fellow and having worked for both the FDA’s Office of Chief Counsel, he has a J.D. from Washington

less

InterestsView All (6)

Uploads

Papers by Seth Whitelaw

Drug Pricing—The Next Compliance Waterloo

Mitchell Hamline Law Review, 2018

hhs-nominee-prescription-drug-prices-too-high [https://perma.cc/S443-C6FN] (quoting the opening s... more

Download

Free Speech and Scientific Exchange: Testing the Limits of FDA's Authority to Regulate Manufacturer Scientific Discussions

Indiana Health Law Review

Law, was previously chair of the ABA Life Sciences Interest Group and served as Director of Compl... more Law, was previously chair of the ABA Life Sciences Interest Group and served as Director of Compliance for PhaCTMI, an industry consortium of Medical Information professionals. He also interviews people on his popular DarshanTalks podcast focused on legal, regulatory and compliance updates in the Life Sciences industry. The views expressed in this article are solely those of the authors and do not represent the views of any current or former employers. This Article is not intended to provide legal advice or substitute for appropriate legal representation. 1. As used throughout this Article, "speech" describes both oral and written materials. 2.

Download